Literature DB >> 27645751

Intestinal Transplant Inflammation: the Third Inflammatory Bowel Disease.

Alexander Kroemer1, Christopher Cosentino2, Jason Kaiser2, Cal S Matsumoto2, Thomas M Fishbein2.   

Abstract

Intestinal transplantation is the most immunologically complex of all abdominal organ transplants. Understanding the role both humoral and innate and adaptive cellular immunity play in intestinal transplantation is critical to improving outcomes and increasing indications for patients suffering from intestinal failure. Recent findings highlighting the impact of donor-specific antibodies on intestinal allografts, the role of NOD2 as a key regulator of intestinal immunity, the protective effects of innate lymphoid cells, and the role of Th17 in acute cellular rejection are reviewed here.

Entities:  

Keywords:  Antimicrobial peptides; Donor-specific antibodies; Innate lymphoid cells; Intestinal transplantation; NOD2; Th17 cells

Mesh：

Substances：

Year:  2016        PMID： 27645751     DOI： 10.1007/s11894-016-0530-0

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


  49 in total

1.  Salvage therapy for refractory rejection and persistence of donor-specific antibodies after intestinal transplantation using the proteasome inhibitor bortezomib.

Authors:  Undine A Gerlach; Constanze Schoenemann; Nils Lachmann; Martin Koch; Andreas Pascher
Journal:  Transpl Int       Date:  2010-12-14       Impact factor: 3.782

2.  What's hot, what's new in clinical organ transplantation: report from the American Transplant Congress 2015.

Authors:  R S Sung
Journal:  Am J Transplant       Date:  2015-10-13       Impact factor: 8.086

3.  NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine.

Authors:  T Fishbein; G Novitskiy; L Mishra; C Matsumoto; S Kaufman; S Goyal; K Shetty; L Johnson; A Lu; A Wang; F Hu; B Kallakury; D Lough; M Zasloff
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

4.  Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.

Authors:  J Marius Munneke; Andreas T Björklund; Jenny M Mjösberg; Karin Garming-Legert; Jochem H Bernink; Bianca Blom; Cynthia Huisman; Marinus H J van Oers; Hergen Spits; Karl-Johan Malmberg; Mette D Hazenberg
Journal:  Blood       Date:  2014-05-22       Impact factor: 22.113

5.  Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatus.

Authors:  Melissa A Gessner; Jessica L Werner; Lauren M Lilly; Michael P Nelson; Allison E Metz; Chad W Dunaway; Yvonne R Chan; Wenjun Ouyang; Gordon D Brown; Casey T Weaver; Chad Steele
Journal:  Infect Immun       Date:  2011-10-28       Impact factor: 3.441

Review 6.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

Authors:  Gregory F Sonnenberg; Lynette A Fouser; David Artis
Journal:  Nat Immunol       Date:  2011-05       Impact factor: 25.606

7.  Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies.

Authors:  Chandrashekhar Kubal; Richard Mangus; Romil Saxena; Andrew Lobashevsky; Nancy Higgins; Jonathan Fridell; A Joseph Tector
Journal:  Transplantation       Date:  2015-08       Impact factor: 4.939

8.  Interleukin-23 drives intestinal inflammation through direct activity on T cells.

Authors:  Philip P Ahern; Chris Schiering; Sofia Buonocore; Mandy J McGeachy; Dan J Cua; Kevin J Maloy; Fiona Powrie
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

9.  Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration.

Authors:  Caroline A Lindemans; Marco Calafiore; Anna M Mertelsmann; Margaret H O'Connor; Marcel R M van den Brink; Alan M Hanash; Jarrod A Dudakov; Robert R Jenq; Enrico Velardi; Lauren F Young; Odette M Smith; Gillian Lawrence; Juliet A Ivanov; Ya-Yuan Fu; Shuichiro Takashima; Guoqiang Hua; Maria L Martin; Kevin P O'Rourke; Yuan-Hung Lo; Michal Mokry; Monica Romera-Hernandez; Tom Cupedo; Lukas Dow; Edward E Nieuwenhuis; Noah F Shroyer; Chen Liu; Richard Kolesnick
Journal:  Nature       Date:  2015-12-09       Impact factor: 49.962

10.  Phenotypic and functional features of human Th17 cells.

Authors:  Francesco Annunziato; Lorenzo Cosmi; Veronica Santarlasci; Laura Maggi; Francesco Liotta; Benedetta Mazzinghi; Eliana Parente; Lucia Filì; Simona Ferri; Francesca Frosali; Francesco Giudici; Paola Romagnani; Paola Parronchi; Francesco Tonelli; Enrico Maggi; Sergio Romagnani
Journal:  J Exp Med       Date:  2007-07-16       Impact factor: 14.307
View more
  7 in total

Review 1.  The parallel paradigm between intestinal transplant inflammation and inflammatory bowel disease.

Authors:  Leonid Belyayev; Katrina Loh; Thomas M Fishbein; Alexander Kroemer
Journal:  Curr Opin Organ Transplant       Date:  2019-04       Impact factor: 2.640

2.  Type 3 innate lymphoid cells are associated with a successful intestinal transplant.

Authors:  Jiman Kang; Katrina Loh; Leonid Belyayev; Priscilla Cha; Mohammed Sadat; Khalid Khan; Yuriy Gusev; Krithika Bhuvaneshwar; Habtom Ressom; Sangeetha Moturi; Jason Kaiser; Jason Hawksworth; Simon C Robson; Cal S Matsumoto; Michael Zasloff; Thomas M Fishbein; Alexander Kroemer
Journal:  Am J Transplant       Date:  2020-07-21       Impact factor: 8.086

3.  Glimmers of hope for intestinal transplantation.

Authors:  Alexander Kroemer
Journal:  Am J Transplant       Date:  2020-05-20       Impact factor: 8.086

4.  Long-Term Signs of T Cell and Myeloid Cell Activation After Intestinal Transplantation With Cellular Rejections Contributing to Further Increase of CD16+ Cell Subsets.

Authors:  Nadja Stobutzki; Stephan Schlickeiser; Mathias Streitz; Katarina Stanko; Kim-Long Truong; Levent Akyuez; Katrin Vogt; Christine Appelt; Andreas Pascher; Olga Blau; Undine A Gerlach; Birgit Sawitzki
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

5.  Immunologic Complications and Graft Survival in Crohn's Disease and NOD2 Mutant Non-Crohn's Disease Adult Recipients Following Intestine Transplantation.

Authors:  Leonid Belyayev; Jason Hawksworth; Khalid Khan; Stuart Kaufman; Sukanya Subramanian; Alexander Kroemer; Katrina Loh; Raffaele Girlanda; Thomas M Fishbein; Cal S Matsumoto
Journal:  Transplant Direct       Date:  2020-05-21

6.  Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab.

Authors:  Alexander Kroemer; Leonid Belyayev; Khalid Khan; Katrina Loh; Jiman Kang; Anju Duttargi; Harmeet Dhani; Mohammed Sadat; Oswaldo Aguirre; Yuriy Gusev; Krithika Bhuvaneshwar; Bhaskar Kallakury; Christopher Cosentino; Brenna Houlihan; Jamie Diaz; Sangeetha Moturi; Nada Yazigi; Stuart Kaufman; Sukanya Subramanian; Jason Hawksworth; Raffaelle Girlanda; Simon C Robson; Cal S Matsumoto; Michael Zasloff; Thomas M Fishbein
Journal:  Am J Transplant       Date:  2020-09-25       Impact factor: 8.086

7.  Safe and Successful Treatment of Acute Cellular Rejection of an Intestine and Abdominal Wall Transplant With Vedolizumab.

Authors:  Guido Trentadue; Gursah Kats-Ugurlu; Tjasso Blokzijl; Gilles Fh Diercks; Jan Willem Haveman; Klaas Nico Faber; Gerard Dijkstra
Journal:  Transplant Direct       Date:  2020-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.